Orphazyme CEO on sale: "It’s sad, but we tried everything"
![Photo: Nikolaj Skydsgaard/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14096646.ece/ALTERNATES/schema-16_9/20210618-130542-1-6061x3402ma%2520(4).jpg)
A small sum of money, a legal suit, and a shadow on the stock market.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme is now officially in American hands
For subscribers
Orphazyme's fate sealed as creditors approve Kempharm sale
For subscribers